Recent News

New study led by UNC Lineberger researchers explains why HIV is not cleared by the immune system

New study led by UNC Lineberger researchers explains why HIV is not cleared by the immune system

Jenny Ting, Ph.D. and her colleagues report research findings in Cell Host & Microbe that further explain the role of host proteins in viral replication and the innate immune response to HIV infection.

New study led by UNC Lineberger researchers explains why HIV is not cleared by the immune system - Read More…

Older women, especially blacks, receive targeted breast cancer treatment at low rates

Older women, especially blacks, receive targeted breast cancer treatment at low rates

Katherine Reeder-Hayes, MD, MBA, and her colleagues report that women age 66 and older who have HER2-positive breast cancer were less likely than younger women to be treated with trastuzumab (Herceptin), a proven, yet expensive, drug therapy.

Older women, especially blacks, receive targeted breast cancer treatment at low rates - Read More…

Studies address link between obesity and basal-like breast cancer

Studies address link between obesity and basal-like breast cancer

Recent work from the laboratory of Liza Makowski, PhD, UNC Lineberger member and assistant professor of nutrition at the UNC Gillings School of Global Public Health, explores two possibilities for breaking the link between obesity and basal-like breast cancer.

Studies address link between obesity and basal-like breast cancer - Read More…

40th annual scientific symposium to focus on targeted cancer treatments

40th annual scientific symposium to focus on targeted cancer treatments

UNC Lineberger's annual scientific symposium, “Molecularly Targeted Cancer Therapies from Bench to Bedside,” will be held April 11-12 at The William and Ida Friday Center for Continuing Education. Thanks to event supporters, attendance is free and the cost to for lunch is minimal at $16 per day. Registration is open until 5 p.m. on Wednesday, April 6.

40th annual scientific symposium to focus on targeted cancer treatments - Read More…